Novo Nordisk A/SNVONYSE
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank86
3Y CAGR+21.7%
5Y CAGR+9.6%
Studio
Year-over-Year Change

Year-over-year book value per share growth

3Y CAGR
+21.7%/yr
vs +31.6%/yr prior
5Y CAGR
+9.6%/yr
Recent acceleration
Acceleration
-9.8pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202535.42%
202435.53%
202329.00%
202219.64%
2021590.68%
202022.40%
2019-82.99%
20186.56%
201712.58%
2016-1.99%